Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gordon

Showing results (171-180 of 201) with videos related to

Pageof 21
Sort By:
Journal of Substance Abuse Treatment|August 30, 2017
Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervisionAshleigh A Allen, Donna T Chen, Richard J Bonnie, et al.
ACS Central Science|April 1, 2024
Dynamic Manipulation of Droplets on Liquid-Infused Surfaces Using Photoresponsive SurfactantXichen Liang, Kseniia M Karnaukh, Lei Zhao, et al.
Advances in Therapy|March 10, 2025
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADEXuan Wang, Ankit Pahwa, Mary T Bausch-Jurken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2020
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of RipretinibFilip Janku, Albiruni R Abdul Razak, Ping Chi, et al.
The Oncologist|August 20, 2020
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I StudyJohanna Bendell, Sunil Sharma, Manish R Patel, et al.
Substance Abuse|January 24, 2012
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentionsPeter D Friedmann, Randall Hoskinson, Michael Gordon, et al.
Journal for Immunotherapy of Cancer|March 13, 2025
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancerOladapo O Yeku, Minal Barve, Winston W Tan, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 studyShailender Bhatia, Brendan Curti, Marc S Ernstoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2018
Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I StudyManish A Shah, Alexander Starodub, Sunil Sharma, et al.
The Lancet. Oncology|December 9, 2017
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trialManish R Patel, John Ellerton, Jeffrey R Infante, et al.
Pageof 21

Showing results (171-180 of 201) with videos related to

Sort By:
Pageof 21
Journal of Substance Abuse Treatment|August 30, 2017
Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervisionAshleigh A Allen, Donna T Chen, Richard J Bonnie, et al.
ACS Central Science|April 1, 2024
Dynamic Manipulation of Droplets on Liquid-Infused Surfaces Using Photoresponsive SurfactantXichen Liang, Kseniia M Karnaukh, Lei Zhao, et al.
Advances in Therapy|March 10, 2025
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADEXuan Wang, Ankit Pahwa, Mary T Bausch-Jurken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2020
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of RipretinibFilip Janku, Albiruni R Abdul Razak, Ping Chi, et al.
The Oncologist|August 20, 2020
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I StudyJohanna Bendell, Sunil Sharma, Manish R Patel, et al.
Substance Abuse|January 24, 2012
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentionsPeter D Friedmann, Randall Hoskinson, Michael Gordon, et al.
Journal for Immunotherapy of Cancer|March 13, 2025
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancerOladapo O Yeku, Minal Barve, Winston W Tan, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 studyShailender Bhatia, Brendan Curti, Marc S Ernstoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2018
Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I StudyManish A Shah, Alexander Starodub, Sunil Sharma, et al.
The Lancet. Oncology|December 9, 2017
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trialManish R Patel, John Ellerton, Jeffrey R Infante, et al.
Pageof 21